News Search Results

Displaying Results 2951-2975 of 4476 "biotechnology"

Jul 14, 2025, 12:52 ET Perfume Ingredient Chemicals Market to Reach USD 11.43 Billion by 2032, Reports Credence Research

suppliers including BASF and Sensient support mass-market production with essential aroma compounds. The market is increasingly shaped by innovation in biotechnology, growing regulatory compliance, and rising demand for natural, allergen-free formulations, driving collaboration across all competitive tiers.

More news about: Credence Research Inc.


Jul 14, 2025, 11:30 ET Geotechnical Construction Services Market Size US$3.83 billion by 2031, Experiences Growth Due to Increased Infrastructure Development Across the Globe | The Insight Partners

consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact

More news about: The Insight Partners


Jul 14, 2025, 11:15 ET Battery Energy Storage System Market Size US$143.28 billion by 2031, Experiences Growing Focus on Establishing Vigorous Storage Infrastructure | The Insight Partners

consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.  

More news about: The Insight Partners


Jul 14, 2025, 11:00 ET Anesthesia Monitoring Devices Market Size expected to reach US$5.93 billion by 2031| The Insight Partners

consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact

More news about: The Insight Partners


Jul 14, 2025, 08:28 ET Egret Therapeutics Appoints Dr. Geoffrey Ling to Scientific Advisory Board - Advancing its Mission to Address Critical Military Health Needs

Egret Therapeutics, a portfolio company of Turret Capital Management, is a clinical stage biotechnology company focused on function preservation following acute injuries NEW YORK,

More news about: Turret Capital Management


Jul 14, 2025, 08:15 ET ZINZINO AB (PUBL.): ZINZINO INITIATES NEGOTIATIONS FOR PART OWNERSHIP IN ANDORRA-BASED XION INTERNATIONAL GROUP FOR FURTHER DEVELOPMENT OF PROPRIETARY OMEGA-3 OIL AND SPIRULINA

strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global scale with innovative biotechnology and a pioneering product portfolio marketed through direct sales.  Xion is an innovative, proprietary production company based in

More news about: Zinzino


Jul 14, 2025, 08:05 ET FITCI and McBee Moore & Vanik IP, LLC form "Power Partnership"

firm based in Frederick, MD, and Tysons Corner, VA, specializes in chemistry, biotechnology, materials science, medical technology, and pharmaceuticals. Their expertise aligns seamlessly with FITCI's mission as a nonprofit to cultivate

More news about: FITCI


Jul 14, 2025, 08:00 ET ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction

XenoTherapeutics, Inc. ("Xeno"), a non-profit biotechnology company, under which Xeno will acquire (the "Transaction") all of the issued and outstanding common shares of ESSA (the "Common Shares"). XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ: XOMA), the biotechnology royalty aggregator, is acting as the

More news about: ESSA Pharma Inc


Jul 14, 2025, 07:00 ET Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First Gene-Agnostic Therapy to Treat Retinitis Pigmentosa

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative

More news about: Nanoscope Therapeutics


Jul 14, 2025, 03:38 ET Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform

worldwide through early R&D collaboration models." About Illimis Therapeutics Illimis Therapeutics is a pioneering biotechnology company at the forefront of developing innovative therapies for challenging central nervous system (CNS) and immune-related diseases. The company's

More news about: Illimis Therapeutics


Jul 14, 2025, 03:00 ET Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot

TURKU, Finland, July 14, 2025 /PRNewswire/ -- Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing announces the results of a clinical pilot study published

More news about: Genomill Health


Jul 14, 2025, 03:00 ET Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot

TURKU, Finland, July 14, 2025 /PRNewswire/ -- Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing announces the results of a clinical pilot study published

More news about: Genomill Health


Jul 14, 2025, 02:43 ET MGI Tech Won Green World Award for Sustainable Contribution to Thai Mangroves Conservation Efforts

focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various

More news about: MGI Tech


Jul 14, 2025, 02:07 ET MGI Tech Won Green World Award for Sustainable Contribution to Thai Mangroves Conservation Efforts

focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various

More news about: MGI Tech


Jul 13, 2025, 22:42 ET Global Times: Readers' Reflections: Building BRICS into a primary channel for strengthening solidarity and cooperation among Global South nations: Egyptian scholar

initiatives like the BRICS Action Plan for Innovation Cooperation can stimulate technological progress, especially in artificial intelligence, biotechnology, and green energy. Collaborations with Chinese and Indian educational institutions can enhance Egypt's workforce

More news about: Global Times


Jul 13, 2025, 20:00 ET CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO

On July 3, 2025, a U.S.-based biotechnology — the sole appellant among the original two opponents — formally withdrew its appeal against the EPO Opposition Division's earlier decision to maintain

More news about: CARsgen Therapeutics


Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE

global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers.  The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects

More news about: Pomerantz LLP


Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG

[Click here for information about joining the class action]  PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. 

More news about: Pomerantz LLP


Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD

Medicine Program focuses on "the use of additive manufacturing for human organ transplantation."  Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients

More news about: Pomerantz LLP


Jul 11, 2025, 11:00 ET High-Speed Cable Market Size to Reach USD 24.99 billion in 2031, Growing at a CAGR of 10.2%, | The Insight Partners

consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact

More news about: The Insight Partners


Jul 11, 2025, 06:55 ET Personal Care Ingredients Market worth $17.00 billion by 2030 - Exclusive Report by MarketsandMarkets™

lifestyles and the rise of e-commerce, is contributing to increased product adoption across diverse geographies and demographics. Innovations in biotechnology, green chemistry, and cold processing technologies are facilitating the development of high-performance ingredients that align with clean beauty

More news about: MarketsandMarkets


Jul 10, 2025, 14:55 ET LevEllis, Inc. Announces the Launch of PROVOQUE™: A Revolutionary Regenerative Skincare Serum

PROVOQUE™, a groundbreaking regenerative skincare serum. This innovative physician dispensed medical grade skincare product utilizes advanced biotechnology to restore, repair, and renew the skin, setting a new standard in the skincare industry.

More news about: LevEllis


Jul 10, 2025, 11:54 ET REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular Dystrophy

and independence, required support for breathing, cardiomyopathy and premature death. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field

More news about: REGENXBIO Inc.


Jul 10, 2025, 11:42 ET Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

standardized process development and manufacturing operations. About IGI  IGI is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing

More news about: Ichnos Glenmark Innovation


Jul 10, 2025, 11:23 ET Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

standardized process development and manufacturing operations. About IGI  IGI is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing

More news about: Ichnos Glenmark Innovation


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.